Pharmaceutical Facility – Demolition Support GlaxoSmithKline Facility, Cairo, Egypt
Key Project Elements • Technical Review of Site Manual Demolition • Health and Safety Assessment of Demolition Methods • Evaluation of Demolition Options
• Recommendation of Safe
Demolition Methods, Equipment and Contractors
CRA provided consultancy services to review the current conditions of two multi-‐story concrete administrative buildings that required demolition due to deficiencies of the structural design to withstand local seismic loading. CRA also completed a technical and health and safety review of current Egyptian demolition practices (entirely manual labour) and evaluated alternatives that might be available in Egypt or could be easily imported into the country to facilitate the demolition. Through the assessment of the design, size, type of construction, and structural deficiencies, CRA recommended that the structures be demolished using mechanical means to minimise direct and potentially fatal risks to human health, the surrounding property (including a cemetery) and GSK and third-‐party owned adjacent structures. Following an assessment of options, and through a detailed consultation with the Egyptian contractor, CRA recommended a safe demolition methodology to enable the Egyptian contractor to safely demolish two multi-‐story, reinforced-‐ concrete buildings. CRA further provided liaison between the Egyptian contractor, the local Site personnel, and GSK corporate staff to facilitate the hiring of a European demolition expert company to import equipment and labour to mechanically demolish the building using modern high reach demolition equipment. CRA also provided support to GSK with regards to demolition and health and safety regulatory matters in context of the Site location and international best practice methodologies.